CCM

Camber Capital Management Portfolio holdings

AUM $718M
1-Year Return 4.23%
This Quarter Return
+20.26%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.43B
AUM Growth
+$537M
Cap. Flow
+$154M
Cap. Flow %
6.32%
Top 10 Hldgs %
66.61%
Holding
40
New
2
Increased
9
Reduced
8
Closed
9

Top Buys

1
WBA
Walgreens Boots Alliance
WBA
$120M
2
GSK icon
GSK
GSK
$112M
3
THC icon
Tenet Healthcare
THC
$79.9M
4
BIIB icon
Biogen
BIIB
$49M
5
UHS icon
Universal Health Services
UHS
$34.4M

Top Sells

1
CI icon
Cigna
CI
$42.4M
2
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
$41.3M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
$37.3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
$30.4M
5
ALXN
Alexion Pharmaceuticals Inc
ALXN
$19.5M

Sector Composition

1 Healthcare 88.03%
2 Technology 9.97%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DRNA
26
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11.6M 0.41%
525,000
– –
ANGO icon
27
AngioDynamics
ANGO
$436M
$8.28M 0.29%
540,362
+519,486
+2,488% +$7.96M
CBIO
28
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
$8.27M 0.29%
22,000
-3,000
-12% -$1.13M
ABBV icon
29
AbbVie
ABBV
$375B
– –
0
– –
ATRA icon
30
Atara Biotherapeutics
ATRA
$90.7M
– –
-56,000
Closed -$18.1M
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$11.1B
– –
-400,000
Closed -$30.4M
BMY icon
32
Bristol-Myers Squibb
BMY
$96B
– –
0
– –
CI icon
33
Cigna
CI
$81.5B
– –
-250,000
Closed -$42.4M
GILD icon
34
Gilead Sciences
GILD
$143B
– –
0
– –
IMVT icon
35
Immunovant
IMVT
$2.99B
– –
-438,800
Closed -$15.4M
STRO icon
36
Sutro Biopharma
STRO
$89.9M
– –
-600,000
Closed -$6.03M
VIR icon
37
Vir Biotechnology
VIR
$732M
– –
-16,464
Closed -$565K
GBT
38
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-50,000
Closed -$2.76M
AMAG
39
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
– –
-4,390,000
Closed -$41.3M
1
2